Allan Tobi

2.9k total citations
15 papers, 597 citations indexed

About

Allan Tobi is a scholar working on Molecular Biology, Biomaterials and Immunology and Allergy. According to data from OpenAlex, Allan Tobi has authored 15 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Biomaterials and 4 papers in Immunology and Allergy. Recurrent topics in Allan Tobi's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Cell Adhesion Molecules Research (4 papers). Allan Tobi is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Cell Adhesion Molecules Research (4 papers). Allan Tobi collaborates with scholars based in Estonia, United States and Norway. Allan Tobi's co-authors include Tambet Teesalu, Venkata Ramana Kotamraju, Erkki Ruoslahti, Lorena Simón‐Gracia, Prakash Lingasamy, Shweta Sharma, Sergei Kopanchuk, Päärn Paiste, Rolf Bjerkvig and Toomas Asser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nano Letters.

In The Last Decade

Allan Tobi

15 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allan Tobi Estonia	12	319	166	161	156	99	15	597
Liane Babes Canada	7	191 0.6×	214 1.3×	197 1.2×	238 1.5×	108 1.1×	11	660
Claudia Gottstein Germany	16	354 1.1×	149 0.9×	206 1.3×	198 1.3×	150 1.5×	27	856
Ali C. Ravanpay United States	12	573 1.8×	206 1.2×	123 0.8×	86 0.6×	156 1.6×	26	1.0k
Geng Kou China	20	525 1.6×	196 1.2×	284 1.8×	209 1.3×	193 1.9×	30	898
Joost A.P. Rens Netherlands	12	266 0.8×	197 1.2×	68 0.4×	94 0.6×	148 1.5×	15	596
Hedi Hunt Estonia	7	218 0.7×	145 0.9×	173 1.1×	51 0.3×	66 0.7×	7	422
Stephan Kontos Switzerland	13	307 1.0×	198 1.2×	142 0.9×	253 1.6×	94 0.9×	14	788
Eriya Kenjo Japan	9	602 1.9×	112 0.7×	215 1.3×	94 0.6×	68 0.7×	10	812
Max Nobis United Kingdom	16	577 1.8×	176 1.1×	208 1.3×	83 0.5×	232 2.3×	29	994
D. Christopher Radford United States	12	232 0.7×	202 1.2×	242 1.5×	120 0.8×	111 1.1×	15	586

Countries citing papers authored by Allan Tobi

Since Specialization

Citations

This map shows the geographic impact of Allan Tobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Tobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Tobi more than expected).

Fields of papers citing papers by Allan Tobi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Tobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Tobi. The network helps show where Allan Tobi may publish in the future.

Co-authorship network of co-authors of Allan Tobi

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Tobi. A scholar is included among the top collaborators of Allan Tobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Tobi. Allan Tobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tobi, Allan, et al.. (2025). Peptide-targeted nanoparticles for tumor therapy. Journal of Controlled Release. 387. 114195–114195. 3 indexed citations

Tobi, Allan, Maarja Haugas, Päärn Paiste, et al.. (2024). Protease-activated CendR peptides targeting tenascin-C: mitigating off-target tissue accumulation. Drug Delivery and Translational Research. 14(10). 2945–2961. 4 indexed citations

Simonetti, Boris, James L. Daly, Lorena Simón‐Gracia, et al.. (2022). ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. Proceedings of the National Academy of Sciences. 119(25). e2201980119–e2201980119. 18 indexed citations

Haugas, Maarja, et al.. (2021). In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues. Nucleic Acids Research. 49(7). e38–e38. 38 indexed citations

Lingasamy, Prakash, Sergei Kopanchuk, Allan Tobi, et al.. (2021). PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular Uptake. Pharmaceutics. 13(12). 1998–1998. 11 indexed citations

Simón‐Gracia, Lorena, Vilma Petrikaitė, Allan Tobi, et al.. (2021). Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis. Nanomaterials. 11(12). 3257–3257. 13 indexed citations

Lingasamy, Prakash, Allan Tobi, Sergei Kopanchuk, et al.. (2020). Tumor-penetrating peptide for systemic targeting of Tenascin-C. Scientific Reports. 10(1). 5809–5809. 55 indexed citations

Tobi, Allan, Kalle Kilk, Gary B. Braun, et al.. (2020). Silver Nanocarriers Targeted with a CendR Peptide Potentiate the Cytotoxic Activity of an Anticancer Drug. Advanced Therapeutics. 4(1). 17 indexed citations

Ivanova, Larisa, Ulrike May, Prakash Lingasamy, et al.. (2020). Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa. Molecular Therapy. 28(8). 1833–1845. 20 indexed citations

10.

Säälik, Pille, Prakash Lingasamy, Liat Rousso-Noori, et al.. (2019). Peptide-guided nanoparticles for glioblastoma targeting. Journal of Controlled Release. 308. 109–118. 79 indexed citations

11.

Lingasamy, Prakash, Allan Tobi, Maarja Haugas, et al.. (2019). Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery. Biomaterials. 219. 119373–119373. 56 indexed citations

12.

Scodeller, Pablo, Lorena Simón‐Gracia, Sergei Kopanchuk, et al.. (2017). Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide. Scientific Reports. 7(1). 14655–14655. 135 indexed citations

13.

Hunt, Hedi, Lorena Simón‐Gracia, Allan Tobi, et al.. (2017). Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. Journal of Controlled Release. 260. 142–153. 53 indexed citations

14.

Sharma, Shweta, Venkata Ramana Kotamraju, Tarmo Mölder, et al.. (2017). Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth. Nano Letters. 17(3). 1356–1364. 83 indexed citations

15.

Paiste, Päärn, Allan Tobi, Kazuki N. Sugahara, et al.. (2017). Ratiometric in vivo auditioning of targeted silver nanoparticles. Nanoscale. 9(28). 10094–10100. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact